tiprankstipranks
Trending News
More News >
Skye Bioscience, Inc. (SKYE)
:SKYE
US Market

Skye Bioscience (SKYE) Financial Statements

Compare
269 Followers

Skye Bioscience Financial Overview

Skye Bioscience's market cap is currently $64.14M. The company's EPS TTM is $-0.28; its P/E ratio is ―; Skye Bioscience is scheduled to report earnings on May 8, 2025, and the estimated EPS forecast is $-0.31. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ -124.25K$ -115.00K$ -34.13K$ -1.87K
Operating Income$ 0.00$ -13.67M$ -18.31M$ -7.85M$ -6.29M
EBITDA$ 0.00$ -13.55M$ -12.09M$ -7.81M$ -6.29M
Net Income$ -26.57M$ -37.64M$ -19.48M$ -8.52M$ -6.56M
Balance Sheet
Cash & Short-Term Investments$ 68.42M$ 1.26M$ 1.24M$ 8.98M$ 2.47M
Total Assets$ 72.76M$ 11.94M$ 9.11M$ 9.86M$ 2.67M
Total Debt$ 455.59K$ 4.62M$ 1.93M$ 2.14M$ 1.50M
Net Debt$ -67.96M$ 3.36M$ 682.55K$ -6.85M$ -971.61K
Total Liabilities$ 4.61M$ 14.07M$ 12.12M$ 3.99M$ 2.22M
Stockholders' Equity$ 68.15M$ -2.13M$ -3.01M$ 5.86M$ 450.79K
Cash Flow
Free Cash Flow$ -26.84M$ -13.96M$ -12.77M$ -6.57M$ -6.06M
Operating Cash Flow$ -25.24M$ -13.95M$ -12.74M$ -6.47M$ -6.05M
Investing Cash Flow$ -245.62K$ 6.60M$ 5.21M$ -90.87K$ -7.23K
Financing Cash Flow$ 83.56M$ 16.44M$ -208.79K$ 13.08M$ 6.70M
Currency in USD

Skye Bioscience Earnings and Revenue History

Skye Bioscience Debt to Assets

Skye Bioscience Cash Flow

Skye Bioscience Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis